UnitedHealth (NYSE:UNH) is scheduled to announce Q2 earnings results on Tuesday, July 16th, before market open.
Analysts expect profit of $6.65 per share (+8.3% Y/Y) on revenue of $98.81B (+6.4% Y/Y).
Over the last 2 years, UNH has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
SA analyst Yuval Rotem says, “The company is facing a long list of headwinds, including a cyberattack, rising medical costs, Medicaid redeterminations, and rising competition.
Investors should focus on the long-term secular growth opportunity, as healthcare spending should continue to grow at a fast pace, and UNH is best positioned to capitalize.”
Over the last 3 months, EPS estimates have seen 2 upward revisions and 18 downward. Revenue estimates have seen 2 upward revisions and 12 downward.
UNH has fallen 2.8% YTD, as compared to the broader S&P 500’s gain of 17.7%.
According to SA Quant analysis, the company has a Hold rating whereas Wall Street analysts rate it as Strong Buy.